Tower Research Capital (TRC)’s M3-Brigade Acquisition III Corp. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant MBSC.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-119
Closed -$1K 6731
2022
Q2
$1K Buy
+119
New +$1.2K ﹤0.01% 5930

Other funds holding MBSC.U

Tower Research Capital (TRC)'s MBSC.U Position: Q3 2022 in Review

Tower Research Capital (TRC) sold out of M3-Brigade Acquisition III Corp. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant (MBSC.U) in Q3 2022, closing a stake of 119 shares — an estimated $1K sold.

Tower Research Capital (TRC) first reported a position in MBSC.U in Q2 2022 and held it in 1 quarter. The position peaked at $1K in Q2 2022. 16 funds tracked by Wall St. Rank hold MBSC.U as of Q3 2022.

  • Tower Research Capital (TRC) reported no remaining M3-Brigade Acquisition III Corp. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant position as of Q3 2022 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 119 M3-Brigade Acquisition III Corp. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant shares in Q3 2022, an estimated $1K.
  • Tower Research Capital (TRC) first reported a position in M3-Brigade Acquisition III Corp. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant in Q2 2022 and held it in 1 quarter.
  • Tower Research Capital (TRC)'s M3-Brigade Acquisition III Corp. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant position peaked at $1K in Q2 2022.
  • 16 funds tracked by Wall St. Rank held M3-Brigade Acquisition III Corp. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant as of Q3 2022.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2022, filed 10 Nov 2022.